David C Metz Selected Research

Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)

1/2017	Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.
2/2016	Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression.
8/2013	Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome.
11/2012	Importance of surveillance for multiple endocrine neoplasia-1 and surgery in patients with sporadic Zollinger-Ellison syndrome.
12/2007	Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
4/2005	Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.
2/2003	Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Metz Research Topics

Disease

15	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 12/2005
12	Neoplasms (Cancer) 01/2022 - 12/2005
7	Esophagitis 01/2020 - 09/2004
7	Gastroesophageal Reflux (GERD) 01/2020 - 09/2003
7	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 01/2017 - 02/2003
6	Infections 01/2021 - 06/2004
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2005
4	Achlorhydria (Hypochlorhydria) 08/2013 - 12/2006
4	Hemorrhage 03/2012 - 01/2005
3	Peptic Ulcer (Peptic Ulcers) 01/2021 - 01/2011
3	Carcinoid Tumor (Carcinoid) 01/2020 - 11/2017
3	Body Weight (Weight, Body) 01/2020 - 05/2002
3	Esophageal Achalasia (Megaesophagus) 12/2016 - 08/2002
3	Ulcer 01/2011 - 03/2005
3	Critical Illness (Critically Ill) 05/2010 - 01/2005
2	Leukemia 01/2022 - 04/2005
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2020
2	Dyspepsia (Indigestion) 02/2014 - 06/2004
2	Atrophy 08/2013 - 02/2003
2	Heartburn (Pyrosis) 11/2011 - 06/2004
2	Deglutition Disorders (Dysphagia) 04/2010 - 08/2002
2	Short Bowel Syndrome 07/2009 - 01/2009
2	Diarrhea 01/2009 - 04/2005
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Osteoporotic Fractures 01/2019
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2019
1	Osteoporosis 01/2019
1	Eosinophilic Esophagitis 10/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Gastrinoma 01/2017
1	Lichen Planus (Lichen Ruber Planus) 01/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Esophageal Perforation 12/2016
1	Pneumoperitoneum 12/2016
1	Mediastinal Emphysema (Pneumomediastinum) 12/2016
1	Weight Gain 02/2016
1	Polyps 12/2015
1	Disease Progression 11/2015
1	Bone Fractures (Bone Fracture) 12/2011
1	Symptom Flare Up 11/2011
1	Tracheomalacia 01/2011
1	Peptic Ulcer Hemorrhage 01/2011
1	Airway Obstruction (Choking) 01/2011
1	Shock 01/2011

Drug/Important Bio-Agent (IBA)

13	Proton Pump InhibitorsIBA 01/2019 - 06/2004
9	AcidsIBA 01/2019 - 03/2005
6	GastrinsIBA 01/2020 - 04/2005
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2005
5	Peptide Receptors (Peptide Receptor)IBA 01/2021 - 11/2015
5	Radioisotopes (Radionuclides)IBA 01/2021 - 11/2015
3	Lansoprazole (Prevacid)FDA LinkGeneric 01/2021 - 06/2004
3	telotristat ethylIBA 01/2020 - 11/2017
3	Pantoprazole (Protonix)FDA LinkGeneric 09/2006 - 05/2002
2	AntigensIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2015
2	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2017
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 11/2017
2	BariumIBA 01/2017 - 08/2002
2	Esomeprazole (Nexium)FDA Link 05/2010 - 12/2007
2	Proton Pumps (Proton Pump)IBA 12/2006 - 05/2002
2	AntacidsIBA 09/2006 - 03/2005
2	AntralIBA 04/2005 - 02/2003
2	Sucralfate (Carafate)FDA LinkGeneric 03/2005 - 01/2005
1	Chimeric Antigen ReceptorsIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	tegoprazanIBA 01/2021
1	Chromogranin AIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	lutetium Lu 177 dotatateIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	entinostat (MS 275)IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Yttrium-90IBA 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Capecitabine (Xeloda)FDA Link 01/2018
1	Tryptophan HydroxylaseIBA 11/2017
1	Neprilysin (Neutral Endopeptidase)IBA 01/2017
1	MMEIBA 01/2017
1	CateninsIBA 12/2015
1	Secretin FDA Link 08/2013
1	Dexlansoprazole FDA Link 11/2011
1	Anesthetics (Anesthetic Agents)IBA 01/2011
1	Ketamine FDA LinkGeneric 01/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011

Therapy/Procedure

27	Therapeutics 01/2022 - 02/2003
3	Aftercare (After-Treatment) 01/2021 - 01/2020
2	Contraindications 01/2018 - 09/2004
2	Fundoplication 04/2010 - 09/2004
1	Immunotherapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Therapeutic Embolization 01/2017
1	Myotomy 12/2016
1	Heller Myotomy 12/2016
1	Length of Stay 12/2016
1	Treatment Delay 01/2011
1	Anesthesia 01/2011